Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study
- PMID: 25754547
- PMCID: PMC4457314
- DOI: 10.1002/cncr.29075
Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study
Abstract
Background: Evidence suggests that the risk of breast and prostate cancer is increased among those with a family history of the same disease and particularly among first-degree relatives. However, less is known about the relationship between breast and prostate cancer within families and particularly among minority populations.
Methods: Analyses of participants in the Women's Health Initiative observational cohort who were free of breast cancer at the time of their baseline examination were conducted. Subjects were followed for breast cancer through August 31, 2009. A Cox proportional hazards regression modeling approach was used to estimate the risk of breast cancer associated with a family history of prostate cancer, breast cancer, and both among first-degree relatives.
Results: There were 78,171 eligible participants, and 3506 breast cancer cases were diagnosed during the study period. A family history of prostate cancer was associated with a modest increase in breast cancer risk after adjustments for confounders (adjusted hazard ratio [aHR], 1.14; 95% confidence interval [CI], 1.02-1.26). In a separate analysis examining the joint impact of both cancers, a family history of both breast and prostate cancer was associated with a 78% increase in breast cancer risk (aHR, 1.78; 95% CI, 1.45-2.19). Risk estimates associated with a family history of both breast and prostate cancer were higher among African American women (aHR, 2.34; 95% CI, 1.09-5.02) versus white women (aHR, 1.66; 95% CI, 1.33-2.08).
Conclusions: These findings suggest that prostate cancer diagnosed among first-degree family members increases a woman's risk of developing breast cancer. Future studies are needed to determine the relative contributions of genes and a shared environment to the risk for both cancers.
Keywords: African American; aggregation; epidemiology; family history; genetics.
© 2015 American Cancer Society.
Conflict of interest statement
CONFLICT OF INTEREST DISCLOSURES
The authors made no disclosures.
Similar articles
-
Family history of prostate and colorectal cancer and risk of colorectal cancer in the Women's health initiative.BMC Cancer. 2017 Dec 13;17(1):848. doi: 10.1186/s12885-017-3873-5. BMC Cancer. 2017. PMID: 29237415 Free PMC article.
-
Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer.J Natl Cancer Inst. 1994 Dec 21;86(24):1860-5. doi: 10.1093/jnci/86.24.1860. J Natl Cancer Inst. 1994. PMID: 7990161
-
Breast cancer risk estimates for relatives of white and African American women with breast cancer in the Women's Contraceptive and Reproductive Experiences Study.J Clin Oncol. 2006 Jun 1;24(16):2498-504. doi: 10.1200/JCO.2005.04.1087. J Clin Oncol. 2006. PMID: 16735703
-
Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index.J Natl Cancer Inst. 2015 Nov 5;108(2):djv327. doi: 10.1093/jnci/djv327. Print 2016 Feb. J Natl Cancer Inst. 2015. PMID: 26546117 Free PMC article. Review.
-
Access and barriers to genomic classifiers for breast cancer and prostate cancer in India.Int J Cancer. 2024 Apr 15;154(8):1335-1339. doi: 10.1002/ijc.34784. Epub 2023 Nov 14. Int J Cancer. 2024. PMID: 37962056 Review.
Cited by
-
Novel biomarkers and drug correlations of non-canonical WNT signaling in prostate and breast cancer.Discov Oncol. 2024 Sep 30;15(1):511. doi: 10.1007/s12672-024-01394-2. Discov Oncol. 2024. PMID: 39347881 Free PMC article.
-
Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer.J Urol. 2024 Jun;211(6):754-764. doi: 10.1097/JU.0000000000003927. Epub 2024 Apr 10. J Urol. 2024. PMID: 38598641
-
Hierarchical classification-based pan-cancer methylation analysis to classify primary cancer.BMC Bioinformatics. 2023 Dec 8;24(1):465. doi: 10.1186/s12859-023-05529-0. BMC Bioinformatics. 2023. PMID: 38066424 Free PMC article.
-
Defining the Impact of Family History on Detection of High-grade Prostate Cancer in a Large Multi-institutional Cohort.Eur Urol. 2022 Aug;82(2):163-169. doi: 10.1016/j.eururo.2021.12.011. Epub 2021 Dec 31. Eur Urol. 2022. PMID: 34980493 Free PMC article.
-
First-degree family history of prostate cancer is associated the risk of breast cancer and ovarian cancer.Medicine (Baltimore). 2021 Jan 29;100(4):e23816. doi: 10.1097/MD.0000000000023816. Medicine (Baltimore). 2021. PMID: 33530178 Free PMC article.
References
-
- Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29. - PubMed
-
- Hulka BS, Moorman PG. Breast cancer: hormones and other risk factors. Maturitas. 2001;38:103–113. - PubMed
-
- Stanford JL, Ostrander EA. Familial prostate cancer. Epidemiol Rev. 2001;23:19–23. - PubMed
-
- Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet. 2001;358:1389–1399. - PubMed
Publication types
MeSH terms
Grants and funding
- HHSN268201100001I/HL/NHLBI NIH HHS/United States
- HHSN271201100004C/AG/NIA NIH HHS/United States
- HHSN268201100004I/HL/NHLBI NIH HHS/United States
- HHSN268201100046C/HL/NHLBI NIH HHS/United States
- HHSN268201100003C/WH/WHI NIH HHS/United States
- HHSN268201100003C/WH/WHI NIH HHS/United States
- HHSN271201100004C/AG/NIA NIH HHS/United States
- HHSN268201100002C/WH/WHI NIH HHS/United States
- P30 CA022453/CA/NCI NIH HHS/United States
- HHSN68201100001C/PHS HHS/United States
- HHSN268201100046C/HL/NHLBI NIH HHS/United States
- HHSN268201100003I/HL/NHLBI NIH HHS/United States
- HHSN268201100002I/HL/NHLBI NIH HHS/United States
- R01 CA140314/CA/NCI NIH HHS/United States
- HHSN268201100002C/WH/WHI NIH HHS/United States
- HHSN268201100001C/WH/WHI NIH HHS/United States
- HHSN268201100004C/WH/WHI NIH HHS/United States
- R25 CA122061/CA/NCI NIH HHS/United States
- HHSN268201100004C/WH/WHI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
